These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24933657)

  • 1. Highly infectious CJD particles lack prion protein but contain many viral-linked peptides by LC-MS/MS.
    Kipkorir T; Tittman S; Botsios S; Manuelidis L
    J Cell Biochem; 2014 Nov; 115(11):2012-21. PubMed ID: 24933657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic analysis of host brain components that bind to infectious particles in Creutzfeldt-Jakob disease.
    Kipkorir T; Colangelo CM; Manuelidis L
    Proteomics; 2015 Sep; 15(17):2983-98. PubMed ID: 25930988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High CJD infectivity remains after prion protein is destroyed.
    Miyazawa K; Emmerling K; Manuelidis L
    J Cell Biochem; 2011 Dec; 112(12):3630-7. PubMed ID: 21793041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CJD and Scrapie Require Agent-Associated Nucleic Acids for Infection.
    Botsios S; Manuelidis L
    J Cell Biochem; 2016 Aug; 117(8):1947-58. PubMed ID: 26773845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 25 nm virion is the likely cause of transmissible spongiform encephalopathies.
    Manuelidis L
    J Cell Biochem; 2007 Mar; 100(4):897-915. PubMed ID: 17044041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prions from Sporadic Creutzfeldt-Jakob Disease Patients Propagate as Strain Mixtures.
    Cassard H; Huor A; Espinosa JC; Douet JY; Lugan S; Aron N; Vilette D; Delisle MB; Marín-Moreno A; Peran P; Beringue V; Torres JM; Ironside JW; Andreoletti O
    mBio; 2020 Jun; 11(3):. PubMed ID: 32546613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strain-specific viral properties of variant Creutzfeldt-Jakob disease (vCJD) are encoded by the agent and not by host prion protein.
    Manuelidis L; Liu Y; Mullins B
    J Cell Biochem; 2009 Feb; 106(2):220-31. PubMed ID: 19097123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous production of prions after infectious particles are eliminated: implications for Alzheimer's disease.
    Miyazawa K; Kipkorir T; Tittman S; Manuelidis L
    PLoS One; 2012; 7(4):e35471. PubMed ID: 22509412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synaptic pathology and cell death in the cerebellum in Creutzfeldt-Jakob disease.
    Ferrer I
    Cerebellum; 2002 Jul; 1(3):213-22. PubMed ID: 12879983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Distribution of Prion Protein Allotypes Differs Between Sporadic and Iatrogenic Creutzfeldt-Jakob Disease Patients.
    Moore RA; Head MW; Ironside JW; Ritchie DL; Zanusso G; Choi YP; Priola SA
    PLoS Pathog; 2016 Feb; 12(2):e1005416. PubMed ID: 26840342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative Abundance of apoE and Aβ1-42 Associated with Abnormal Prion Protein Differs between Creutzfeldt-Jakob Disease Subtypes.
    Moore RA; Choi YP; Head MW; Ironside JW; Faris R; Ritchie DL; Zanusso G; Priola SA
    J Proteome Res; 2016 Dec; 15(12):4518-4531. PubMed ID: 27597180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid chemical decontamination of infectious CJD and scrapie particles parallels treatments known to disrupt microbes and biofilms.
    Botsios S; Tittman S; Manuelidis L
    Virulence; 2015; 6(8):787-801. PubMed ID: 26556670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral particles are required for infection in neurodegenerative Creutzfeldt-Jakob disease.
    Manuelidis L; Sklaviadis T; Akowitz A; Fritch W
    Proc Natl Acad Sci U S A; 1995 May; 92(11):5124-8. PubMed ID: 7761460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between deposition of beta-amyloid and pathological prion protein in sporadic Creutzfeldt-Jakob disease.
    Debatin L; Streffer J; Geissen M; Matschke J; Aguzzi A; Glatzel M
    Neurodegener Dis; 2008; 5(6):347-54. PubMed ID: 18349519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two Creutzfeldt-Jakob disease agents reproduce prion protein-independent identities in cell cultures.
    Arjona A; Simarro L; Islinger F; Nishida N; Manuelidis L
    Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8768-73. PubMed ID: 15161970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmission characteristics of heterozygous cases of Creutzfeldt-Jakob disease with variable abnormal prion protein allotypes.
    Ward A; Hollister JR; McNally K; Ritchie DL; Zanusso G; Priola SA
    Acta Neuropathol Commun; 2020 Jun; 8(1):83. PubMed ID: 32517816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.
    Moreno JA; Telling GC
    Methods Mol Biol; 2017; 1658():219-252. PubMed ID: 28861793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of prion infectivity in fixed heart tissue from patients with Creutzfeldt-Jakob disease or amyloid heart disease.
    Priola SA; Ward AE; McCall SA; Trifilo M; Choi YP; Solforosi L; Williamson RA; Cruite JT; Oldstone MB
    J Virol; 2013 Sep; 87(17):9501-10. PubMed ID: 23785217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond PrP9res) type 1/type 2 dichotomy in Creutzfeldt-Jakob disease.
    Uro-Coste E; Cassard H; Simon S; Lugan S; Bilheude JM; Perret-Liaudet A; Ironside JW; Haik S; Basset-Leobon C; Lacroux C; Peoch' K; Streichenberger N; Langeveld J; Head MW; Grassi J; Hauw JJ; Schelcher F; Delisle MB; Andréoletti O
    PLoS Pathog; 2008 Mar; 4(3):e1000029. PubMed ID: 18389084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clusterin solubility and aggregation in Creutzfeldt-Jakob disease.
    Freixes M; Puig B; Rodríguez A; Torrejón-Escribano B; Blanco R; Ferrer I
    Acta Neuropathol; 2004 Oct; 108(4):295-301. PubMed ID: 15235804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.